“ Rituximab in the Treatment of Refractory Myasthenia Gravis : Studying the Outcomes Using MMT Score and Need for Plasmapheresis in Baghdad Teaching Hospital ”. Indian Journal of Forensic Medicine & Toxicology 14, no. 2 (April 29, 2020): 1400–1405. Accessed June 4, 2026. https://medicopublication.com/index.php/ijfmt/article/view/3108.